Iradimed Corp
IRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.24B
Close$
$57.05
37.8% downside
Current Fair Value
37.8% downsideOvervalued by 37.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.24 Billion |
|---|---|
| Enterprise Value | $1.19 Billion |
| Dividend Yield | $1.24 (1.28%) |
| Earnings per Share | $1.77 |
| Beta | 0.91 |
| Outstanding Shares | 12,783,000 |
Return
| Return on Equity | 23.97% |
|---|---|
| Return on Assets | 20.64% |
| Return on Invested Capital | 27.79% |
Valuation & Multiples
| P/E Ratio | 52.26 |
|---|---|
| PEG | 216.67 |
| Price to Sales | 15.28 |
| Price to Book Ratio | 13.1 |
| Enterprise Value to Revenue | 13.79 |
| Enterprise Value to EBIT | 41.86 |
| Enterprise Value to Net Income | 50 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 4, 2026
EPS Estimate
$0.45
Average shareholder expectationRevenue Estimate
$21.32 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$20.35 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 76.38% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 59.89% |
|---|---|
| Total Invested | $249,891▼ 99.97% |
| Investors Holding | 6▼ 225.00% |
ESG Score
No data
About Iradimed Corp
CEO: Roger Susi